Ascelia Pharma AB (publ) (STO: ACE)
Sweden
· Delayed Price · Currency is SEK 2.710
+0.095 (3.63%)
Nov 22, 2024, 5:29 PM CET
Ascelia Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -62.3 | -109.29 | -131.22 | -125.9 | -98.7 | -66.04 | Upgrade
|
| Depreciation & Amortization | 1.05 | 1.05 | 1.05 | 1.03 | 0.83 | 0.06 | Upgrade
|
| Stock-Based Compensation | 5.09 | 2.93 | 1.63 | 5.92 | 7.87 | 3.3 | Upgrade
|
| Other Operating Activities | 3.85 | 0.35 | -11.38 | -11.08 | 5.17 | 4.02 | Upgrade
|
| Change in Accounts Receivable | -1.6 | 1.62 | -1.36 | -0.9 | 1.7 | -7.44 | Upgrade
|
| Change in Accounts Payable | -2.02 | -14.35 | 9.72 | 2.26 | -1.22 | 4.64 | Upgrade
|
| Change in Other Net Operating Assets | -4.05 | -9.11 | 6.31 | 12.11 | -1.17 | 7.15 | Upgrade
|
| Operating Cash Flow | -59.99 | -126.79 | -125.26 | -116.56 | -85.53 | -54.3 | Upgrade
|
| Capital Expenditures | - | - | - | -0.04 | -0.4 | - | Upgrade
|
| Investment in Securities | - | - | - | - | 76.39 | -75 | Upgrade
|
| Other Investing Activities | - | 0.05 | -0.07 | - | - | - | Upgrade
|
| Investing Cash Flow | - | 0.05 | -0.07 | -0.04 | 75.99 | -75 | Upgrade
|
| Long-Term Debt Repaid | - | -0.91 | -1.02 | -0.94 | -0.64 | - | Upgrade
|
| Total Debt Repaid | -8.36 | -0.91 | -1.02 | -0.94 | -0.64 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | 26.09 | -0.91 | -1.02 | -0.94 | -0.64 | -0.06 | Upgrade
|
| Issuance of Common Stock | 105.32 | - | 0.3 | 200.4 | 98.65 | 222.05 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.3 | -0.4 | - | - | Upgrade
|
| Other Financing Activities | -14.47 | -0.03 | -0.08 | -14.19 | -5.29 | -21.81 | Upgrade
|
| Financing Cash Flow | 116.94 | -0.94 | -1.1 | 184.87 | 92.73 | 200.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.23 | -0.02 | 14.38 | 8.64 | -7.02 | -4.48 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 56.73 | -127.7 | -112.04 | 76.91 | 76.17 | 66.41 | Upgrade
|
| Free Cash Flow | -59.99 | -126.79 | -125.26 | -116.6 | -85.92 | -54.3 | Upgrade
|
| Free Cash Flow Per Share | -1.57 | -3.76 | -3.60 | -3.54 | -3.27 | -2.49 | Upgrade
|
| Cash Interest Paid | 3.89 | 0.12 | 0.05 | 0.08 | 0.09 | - | Upgrade
|
| Cash Income Tax Paid | - | -1.17 | -3.77 | -1.02 | 0.09 | - | Upgrade
|
| Levered Free Cash Flow | -25.83 | -87 | -74.73 | -74.23 | -48.32 | - | Upgrade
|
| Unlevered Free Cash Flow | -22.35 | -87 | -74.7 | -74.18 | -48.31 | - | Upgrade
|
| Change in Net Working Capital | -7.41 | 21.31 | -14.92 | -5.09 | -1.68 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.